<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="1209">
  <stage>Registered</stage>
  <submitdate>10/04/2006</submitdate>
  <approvaldate>11/04/2006</approvaldate>
  <actrnumber>ACTRN12606000131550</actrnumber>
  <trial_identification>
    <studytitle>Evaluation of the accuracy of pulse oximeters compared with CO-Oximetry in hypoxaemic normal subjects.</studytitle>
    <scientifictitle>Evaluation of the accuracy of pulse oximeters compared with CO-Oximetry in hypoxaemic normal subjects.</scientifictitle>
    <utrn />
    <trialacronym>Nil</trialacronym>
  </trial_identification>
  <conditions>
    <healthcondition>Hypoxaemia</healthcondition>
    <conditioncode>
      <conditioncode1>Blood</conditioncode1>
      <conditioncode2>Other blood disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Subjects are acutely exposed to a range of hypoxic gas mixtures to induce falls in arterial oxygen saturation in the range 95-70%. Oximeter readings (SpO2) are compared with simultaneously determined CO-oximetry measurements of SaO2 from arterial blood samples. These samples are drawn once a steady state has been achieved at each level of hypoxaemia, usually 3-5 minutes.</interventions>
    <comparator>No comparator.</comparator>
    <control />
    <interventioncode>Other interventions</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Accuracy of SpO2 compared with SaO2</outcome>
      <timepoint>Arterial blood samples are drawn once a steady state has been achieved at each level of hypoxaemia, usually 3-5 minutes.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Response characteristics of the oximeters are assessed during the initial period following step changes in inspired oxygen concentration.</outcome>
      <timepoint>The period is varied but it is usually within 2-3 minutes.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria> Adults </inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>80</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Cardiac or respiratory disease. History of CVA.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs>Screening</purposeobs>
    <duration>Cross-sectional</duration>
    <selection>Defined population</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>1/11/2005</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>12</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>Institute for Breathing and Sleep</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Compumedics Ltd</fundingname>
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>Nil</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Pulse oximeters are used in many areas of clinical medicine and a clear understanding of their performance is critical to appropriate and safe use. This study aims to evaluate the accuracy of a new pulse oximeter under a range of oxygen conditions compared with CO-ocimetry, which is the current reference method for this measurement.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Austin Hospital</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec>02240</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Peter Rochford</name>
      <address>Department of Respiratory and Sleep Medicine
Austin Hospital
Studley Rd
Heidelberg VIC 3081</address>
      <phone>+61 3 94963673</phone>
      <fax />
      <email>peter.rochford@austin.org.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Peter Rochford</name>
      <address>Department of Respiratory and Sleep Medicine
Austin Hospital
Studley Rd
Heidelberg VIC 3081</address>
      <phone>+61 3 94963673</phone>
      <fax />
      <email>peter.rochford@austin.org.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>